Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ependymoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 60 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Recurrence 12 Myelodysplastic Syndromes 12 Leukemia, Biphenotypic, Acute 12 Leukemia 11 Burkitt Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 5 Lymphoma, Mantle-Cell 5 Leukemia, Myelomonocytic, Chronic 5 Neoplasm, Residual 4 Lymphoma 4 Hematologic Neoplasms 4 Sarcoma, Myeloid 3 Hodgkin Disease 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid 2 Targeted Therapy 1 Pyloric Stenosis, Hypertrophic 1 Neurofibromatosis 1 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Temozolomide 2 ONC206 2 Etoposide 2 Cyclophosphamide 2 lutetium Lu 177 dotatate 1 ibrutinib 1 fenofibric acid 1 etoposide phosphate 1 Thalidomide 1 Restraint, Physical 1 Radiotherapy 1 Radiation 1 Magnetic Resonance Spectroscopy 1 Linear Energy Transfer 1 Irinotecan 1 Elasticity Imaging Techniques 1 Cytarabine 1 Celecoxib 1 Bevacizumab 1 Automobiles 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡